Trial · NCT00501631
Adverse events88
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 88
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Injection site pain | General disorders | VIVITROL 380 mg (Double-blind Period) | 54 | 152 | |
| other | Injection site pain | General disorders | Placebo for VIVITROL 380 mg (Double-blind Period) | 59 | 148 | |
| other | Fatigue | General disorders | VIVITROL 380 mg (Double-blind Period) | 15 | 152 | |
| other | Fatigue | General disorders | Placebo for VIVITROL 380 mg (Double-blind Period) | 5 | 148 | |
| other | Injection site induration | General disorders | VIVITROL 380 mg (Double-blind Period) | 7 | 152 | |
| other | Injection site induration | General disorders | Placebo for VIVITROL 380 mg (Double-blind Period) | 3 | 148 | |
| other | Influenza like illness | General disorders | VIVITROL 380 mg (Double-blind Period) | 5 | 152 | |
| other | Influenza like illness | General disorders | Placebo for VIVITROL 380 mg (Double-blind Period) | 3 | 148 | |
| other | Alcoholism | Psychiatric disorders | VIVITROL 380 mg (Double-blind Period) | 25 | 152 | |
| other | Alcoholism | Psychiatric disorders | Placebo for VIVITROL 380 mg (Double-blind Period) | 40 | 148 | |
| other | Sleep disorder | Psychiatric disorders | VIVITROL 380 mg (Double-blind Period) | 8 | 152 | |
| other | Sleep disorder | Psychiatric disorders | Placebo for VIVITROL 380 mg (Double-blind Period) | 10 | 148 | |
| other | Depression | Psychiatric disorders | VIVITROL 380 mg (Double-blind Period) | 9 | 152 | |
| other | Depression | Psychiatric disorders | Placebo for VIVITROL 380 mg (Double-blind Period) | 7 | 148 | |
| other | Depressed mood | Psychiatric disorders | VIVITROL 380 mg (Double-blind Period) | 7 | 152 | |
| other | Depressed mood | Psychiatric disorders | Placebo for VIVITROL 380 mg (Double-blind Period) | 3 | 148 | |
| other | Headache | Nervous system disorders | VIVITROL 380 mg (Double-blind Period) | 25 | 152 | |
| other | Headache | Nervous system disorders | Placebo for VIVITROL 380 mg (Double-blind Period) | 25 | 148 | |
| other | Dizziness | Nervous system disorders | VIVITROL 380 mg (Double-blind Period) | 11 | 152 | |
| other | Dizziness | Nervous system disorders | Placebo for VIVITROL 380 mg (Double-blind Period) | 4 | 148 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00501631/events